ALAINA BEIMBORN: Open Payments
NPI 1881306280 · NEW LONDON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 20 payments from 7 companies in 2025. Trend: 2023 $367 · 2024 $572 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $103 |
| ABBVIE INC. | 4 | $85 |
| Amgen Inc. | 2 | $39 |
| UCB, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Organon LLC | 2 | $14 |
Products named: DUPIXENT, BOTOX, OTEZLA, RINVOQ, Bimzelx, KEYTRUDA.
Industry payments across WI — which companies pay providers there.
